Avecho Biotechnology Ltd has released a press release.
Topical CBD pain study with Lambert Initiative approved
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- Dosing begins in Phase I PK trial testing CBD soft-gel
- Phase I clinical trial testing CBD product-enrolment begins
- June 2021 Quarterly Activities Report & Appendix 4C
- Avecho to Present New CBD Data at GCI Virtual Summit
- Chairs Address and CEO Presentation
Later from Avecho Biotechnology
- September 2021 Quarterly Activities Report & Appendix 4C
- Positive results from Avechos Phase I trial of CBD soft-gel
- AVE Licenses CBD Soft-Gel to Medterra Pharma for Arthritis
- Application for quotation of securities - AVE
- December 2021 Quarterly Activities Report & Appendix 4C
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology